Walgreens results beat estimates on strong pharmacy sales, COVID-19 vaccinations

Popular Categories

Subscribe Here

imageStock Markets32 minutes ago (Oct 14, 2021 07:56AM ET)

(C) Reuters. FILE PHOTO: A Walgreens store is seen in Chicago, Illinois, U.S. February 11, 2021. REUTERS/Eileen T. Meslar

(Reuters) -Walgreens Boots Alliance Inc’s fourth-quarter results beat estimates on higher U.S. and UK pharmacy store sales due to the easing of pandemic-related restrictions and people getting COVID-19 vaccines at its stores.

The company has administered more than 40 million COVID-19 vaccines and over 16 million tests to date, it said.

Same-store sales at its U.S. pharmacies rose 8.8% in the fourth quarter, which included a 485 basis point boost from COVID-19 vaccinations, the company said. Walgreens filled 313 million prescriptions during the quarter.

Shares in the Deerfield, Illinois-based company, one of the largest U.S. pharmacies, rose 1.6% to $48 premarket.

Net income attributable to the company was $627 million, or 72 cents per share, for the quarter ended Aug. 31, compared with a profit of $373 million, or 43 cents per share, a year earlier.

Excluding items, the company earned $1.17 per share, compared with Refinitiv IBES estimates of $1.02 per share.

Revenue rose to $34.26 billion from $30.37 billion, while analysts on average had estimated $33.30 billion.

Walgreens results beat estimates on strong pharmacy sales, COVID-19 vaccinations

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.

Explore

Up Next

Discover

Other Articles